QA: Sibannac Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001313938_2017_Sibannac_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001313938, Sibannac Inc

  xvar xval
0 AssetsCurrent 72,771
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 250,000
4 LiabilitiesCurrent 365,600
5 LiabilitiesNoncurrent 250,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 453,295
8 SellingGeneralAndAdministrativeExpense 269,766
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 0
11 remainder_Revenues 523,677
12 remainder_NetIncome -151,635
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 322,771
1 Liabilities 615,600
2 Expenses 723,061
3 Revenues 523,677
4 StockholdersEquity -292,829
5 NetIncome -351,019
6 ComprehensiveNetIncome -351,019
7 BaseVar 1,168,372
8 EconomicCapitalRatiobeforeLimitedLiability -2.11
9 EconomicCapitalRatio 0.988

Edgar->Model Mapping

Feature Distribution

Change over Time